Company Encyclopedia
View More
name
USANA Health Sciences
USNA.US
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration.
516.59 B
USNA.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Personal Care ProductsIndustry
Industry Ranking10/53
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.20%C
    • Profit Margin1.86%C
    • Gross Margin77.15%A
  • Growth ScoreC
    • Revenue YoY5.88%C
    • Net Profit YoY-68.74%E
    • Total Assets YoY8.24%B
    • Net Assets YoY9.09%B
  • Cash ScoreB
    • Cash Flow Margin5372.12%A
    • OCF YoY5.88%C
  • Operating ScoreA
    • Turnover1.31A
  • Debt ScoreA
    • Gearing Ratio19.96%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Usana Extends Partnership With World-Famous Jamaican Bobsled Team To Help Fuel Their Olympic Dreams

    Dec 4 (Reuters) - USANA Health Sciences Inc:* USANA EXTENDS PARTNERSHIP WITH WORLD-FAMOUS JAMAICAN BOBSLED TEAM TO HELP FUEL THEIR OLYMPIC DREAMS Source text: Further company coverage:

    Reuters·
    US
    USNA
    -2.97%
    Reuters·
    US
    USNA
    -2.97%

    USANA extends partnership with Jamaican Bobsled Team for two more Olympic cycles, supporting their Olympic dreams.

    USANA Health Sciences, Inc. has extended its partnership with the Jamaica Bobsleigh and Skeleton Federation for two more Olympic cycles, effective December 4, 2025. This extension underscores USANA's commitment to supporting Jamaican athletes in winter sports, enhancing their performance through upcoming Olympic events.

    Unusual Whales·
    US
    USNA
    -2.97%
    Unusual Whales·
    US
    USNA
    -2.97%

    Proven Power for Strong Bone Support--USANA's MagneCal D Earns ConsumerLab.com Seal of Approval | USNA Stock News

    USANA (NYSE: USNA) has announced that its MagneCal D supplement has received the ConsumerLab.com Seal of Approval, recognizing its purity, potency, and scientific excellence. This supplement combines calcium, magnesium, and vitamin D to support bone density and overall health. USANA's Chief Commercial Officer, Brent Neidig, emphasized the company's commitment to quality and innovation. The approval validates USANA's rigorous testing and manufacturing standards, reinforcing its position as a leader in nutritional excellence. For more information, visit USANA.com.

    StockTitan·
    US
    USNA
    -2.97%
    StockTitan·
    US
    USNA
    -2.97%

    USANA Director Frederic J. Winssinger Reports Sale of Common Shares

    Frederic J. Winssinger, Director of USANA Health Sciences Inc., reported the sale of common shares. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice. The original content was published via EDGAR on November 10, 2025.

    Reuters·
    US
    USNA
    -2.97%
    Reuters·
    US
    USNA
    -2.97%

    USANA Health Sciences | 10-Q: FY2025 Q3 Revenue Misses Estimate at USD 213.67 M

    LB filings·
    US
    USNA
    -2.97%
    LB filings·
    US
    USNA
    -2.97%
    © 2025 Longbridge｜Disclaimer